and sensitive
biomarkers such as ST2 and Pentraxin-3 (Ptx-3) have prediction potential in HF and primary
Xun, Xu,,
Liang, Yuan,
Gareev, Ilgiz,
Liang, Yanchao,
Liu, Rui,
Wang, Ning,
Yang, Guang (2023) biomarkers. This review focuses on the biological characteristics of lncRNA and its value as a
biomarkerBeilerli, A.,
Gareev, I.,
Beylerli, O.,
Yang, G.,
V.N. Pavlov,
Aliev, G.,
Ahmad, A. (2022) exploitation as diagnostic
biomarkers. Their covalent closed cyclic structure resulting in resistance to RNases
YANG, G.,
SUN, J.,
SHI, H.,
ZHAO, S.,
GAREEV, I.,
BEYLERLI, O.,
PAVLOV, V.,
IZMAILOV, A. (2020) RNAs are of great interest as potential noninvasive
biomarkers for tumors, lipid disorders, diabetes mellitus
ZAGIDULLIN, N.SH.,
HAMITOVA, A.,
LAKMAN, I.,
KRIONI, I.,
GAREEVA, D.,
ZULKARNEEV, R.,
TULBAEV, E. (2020) The
biomarkes NT-proBNP, ST2 and Pentraxin-3 (Ptx-3) have emerged as potential powerful tools
attention in this context. They emerge as pivotal
biomarkers and potential therapeutic targets, offering
factors or enhancing the sensitivity and specificity of existing markers. Immunological
biomarkers (both
МАРКЕРЫ ИММУНОКОМПРОМЕТАЦИИ ПРИ ВОЗДЕЙСТВИИ КСЕНОБИОТИКОВПисарев, В.М.,
Тутельян, А.В.,
Хасанова, Г.М.,
Pisarev, V.M.,
Tutelyan, A.V.,
Khasanova, G.M. (2018) of xenobiotic factors of the environment.
The analysis of
biomarkers of immunotoxicity of ecotoxicants
Isaeva, A,
Averyanov, S,
Iskhakov, I,
Galimov, S,
Galimova, E,
Kiniabaev, T (2021) Biomarkers of inflammation can be used as indicators for monitoring the treatment of periodontal
Gareev, Ilgiz,
Aamir, Ahmad,
Jiaqi, Wang,
Aferin, Beilerli,
Tatiana, Ilyasova,
Albert, Sufianov,
Ozal, Beylerli (2023) is confirmed
- non-invasive
biomarkers can become the key to solving these and many other
problems of modern